First of all, the global pharmaceutical market is expected to maintain a growth rate of more than 8% in 2014, and the emerging pharmaceutical market is likely to maintain a greater growth rate. The international and domestic market demand for API will continue to grow.

Secondly, many of China's API varieties occupy high market share in the international market, with obvious advantages in scale, which cannot be replaced by other countries in the short term.

Third, although the price of API in China has increased significantly due to the impact of multiple factors, these rising factors are rigid and are unlikely to significantly decrease in 2013 and affect the total export volume of API in China. In terms of the import of API in 2012, the average price increased by 28.21%. In the face of the general increase in the price of API in the world, the comparative advantage of China's API price still exists.

Fourth, The efforts of Chinese enterprises to avoid homogeneous competition and develop characteristic API, as well as the practice of many enterprises aiming at developed markets, actively passing high-end market certification and constantly improving the quality of export products, will expand the export space of China's API.

Fifth, the continuous introduction and implementation of the state export policy will also play an important role in promoting the export growth of API.